Package Label-principal Display Panel (150 mg (30 Tablets Bottle))
Not available.*
Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 65862-421
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 65862-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label-principal Display Panel (200 mg (30 Tablets Bottle))
Not available. seems to have failed to recognize any readable characters.*
Package Label-principal Display Panel (250 mg (30 Tablets Bottle))
Tenofovir Disoproxil Fumarate Tablets is a prescription drug that comes in film-coated tablet form. Each tablet contains 200mg of tenofovir disoproxil fumarate, which is equivalent to 163mg of tenofovir disoproxil. This drug is manufactured by Aurobindo Pharma USA, Inc. in India and comes in a bottle of 30 tablets. The usual dosage of this drug can be found in the prescribing information. It should be stored between 20° to 257 (63° to 77°F) with allowance excursions permitted to 15° to 30°C (59° o 86°F) [see USP Controlled Room Temperature]. Before use, ensure that the seal over the bottle opening is not broken or missing, and the container should be kept tightly closed.*
Package Label-principal Display Panel (300 mg (30 Tablets Bottle))
This is a description of a medication called Tenofovir Disoproxil Fumarate Tablets. It comes in a package of 30 Unit-dose Tablets and has an NDC number of 65862-819-03. The tablets contain 200g of vl oo umart, Wi s gt o 1630t otoutGsopr. The rest of the text seems to be errors and cannot be understood properly.*
Tenofovir Fig5
Tenofovir Fig6
This is a description of a prescription drug called Tenofovir Disoproxil Fumarate Tablets. It comes in a pack of 30310 unit dose tablets with a strength of 234mg. It is indicated for HIV-1 infected adult patients. The NDC code is 65862-820-03. The rest of the text seems to be unclear and not readable.*
Tenofovir Fig7
This is a prescription drug called Tenofovir Disoproxil Fumarate Tablets, manufactured in India and distributed by Aurobindo Pharma USA, Inc. Each film-coated tablet contains 300mg of tenofovir disoprosilfumarate, equivalent to 245mg of tenofovir disoproxi. This drug is meant to be stored at 20° to 25°C and should only be dispensed in its original container. The recommended dosage and administration are listed in the packaging insert. If the seal over the bottle opening is broken or missing, do not use it. The code TS/DRUGS/19/1993 and NDC 65862-421-30 are printed on the packaging.*
Tenofovir Structure (Tenofovir Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
